289 related articles for article (PubMed ID: 16772658)
21. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
22. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
Tanenberg RJ
Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
[TBL] [Abstract][Full Text] [Related]
23. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
Spellman CW
J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
[TBL] [Abstract][Full Text] [Related]
24. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
Liebl A
Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
[TBL] [Abstract][Full Text] [Related]
25. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
26. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
Massi-Benedetti M; Orsini-Federici M
Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
[TBL] [Abstract][Full Text] [Related]
27. Intensifying insulin therapy in patients with type 2 diabetes mellitus.
Hirsch IB
Am J Med; 2005 May; 118 Suppl 5A():21S-6S. PubMed ID: 15850550
[TBL] [Abstract][Full Text] [Related]
28. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
29. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
Rakel RE
Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
[TBL] [Abstract][Full Text] [Related]
30. Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes.
Gin H; Rigalleau V
Diabetes Metab; 2000 Sep; 26(4):265-72. PubMed ID: 11011218
[TBL] [Abstract][Full Text] [Related]
31. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes.
Tibaldi J
South Med J; 2009 Jan; 102(1):60-6. PubMed ID: 19077774
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
Slama G
Int J Clin Pract Suppl; 2000 Sep; (112):9-12. PubMed ID: 11064945
[No Abstract] [Full Text] [Related]
33. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
[No Abstract] [Full Text] [Related]
34. Genetically engineered insulin analogs: diabetes in the new millenium.
Vajo Z; Duckworth WC
Pharmacol Rev; 2000 Mar; 52(1):1-9. PubMed ID: 10699152
[TBL] [Abstract][Full Text] [Related]
35. Important aspects of self-management education in patients with diabetes.
Stam DM; Graham JP
Pharm Pract Manag Q; 1997 Jul; 17(2):12-25. PubMed ID: 10168174
[TBL] [Abstract][Full Text] [Related]
36. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
Gerich JE; Odawara M; Terauchi Y
Curr Med Res Opin; 2007 Aug; 23(8):1791-8. PubMed ID: 17610805
[TBL] [Abstract][Full Text] [Related]
37. The many faces of type 2 diabetes.
Flood T
Postgrad Med; 2010 Jul; 122(4):218-23. PubMed ID: 20675986
[TBL] [Abstract][Full Text] [Related]
38. Mealtime glucose regulation in type 2 diabetes.
Tuomilehto J; Del Prato S
Int J Clin Pract; 2001; 55(6):380-3. PubMed ID: 11501227
[TBL] [Abstract][Full Text] [Related]
39. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities.
Haas LB
J Am Med Dir Assoc; 2007 Oct; 8(8):502-10. PubMed ID: 17931573
[TBL] [Abstract][Full Text] [Related]
40. The nuts and bolts of achieving end points with real-time continuous glucose monitoring.
Wolpert HA
Diabetes Care; 2008 Feb; 31 Suppl 2():S146-9. PubMed ID: 18227476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
